New-onset chronic inflammatory demyelinating polyradiculoneuropathy after COVID-19 infection: a case report.
| Autor: | Abedi Samakoush M; Antimicrobial Resistance Research Center., Davoodi L; Antimicrobial Resistance Research Center, Communicable Diseases Institute, and Department of Infectious Diseases., Khademian M; Student Research Committee, Faculty of Medicine., Kargar-Soleimanabad S; Student Research Committee, Faculty of Medicine., Abedini MA; Mazandaran University of Medical Sciences, Sari, Iran. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Annals of medicine and surgery (2012) [Ann Med Surg (Lond)] 2023 Jul 31; Vol. 85 (10), pp. 5031-5034. Date of Electronic Publication: 2023 Jul 31 (Print Publication: 2023). |
| DOI: | 10.1097/MS9.0000000000000352 |
| Abstrakt: | Introduction and Importance: SARS-CoV-2 infection, besides respiratory symptoms, as cardinal manifestation, may present with neurological involvement. Immune-mediated polyradiculoneuropathy is one of the important neurological complications manifested by COVID-19 mainly includes Guillain-Barré syndrome (GBS), treatment-related fluctuation of GBS, and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Also, there are several reports of COVID-19 vaccine-related GBS and CIDP. According to possible severe manifestations of neuropathies like respiratory failure, considering these complications for early diagnosis and treatment is very important. Case Presentation: The authors presented a 67-year-old woman with severe weakness in upper and lower extremities, the patient was diagnosed as case with CIDP initiated after COVID-19 virus infection and/or vaccination that experienced one relapse in 11 months. In both episodes, treatment with intravenous immunoglobulin started and the patient respond. Clinical Discussion: To the best of our knowledge, this is one of the first reported cases with a typical chronic course of CIDP associated with COVID-19 virus infection and/or vaccination. Conclusion: Considering this complication and differentiation between GBS and CIDP, and then initiating maintenance therapy can prevent long-term disability. Competing Interests: The authors declare that no conflict of interest.Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article (Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|